Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Thayer

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Rhode Island Medical Journal|September 1, 1978
Toxic megacolon in inflammatory bowel disease: a new perspectiveR Carman, E A Iannuccilli, W R Thayer
Gastroenterology|February 1, 1976
The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) proteinP A Feinstein, S R Kaplan, W R Thayer
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1995
Rifabutin use in inflammatory bowel diseaseK W To, W G Tsiaras, W R Thayer
Antimicrobial Agents and Chemotherapy|August 1, 1993
Use of rifabutin in treatment of systemic Mycobacterium paratuberculosis infection in miceR J Chiodini, J M Kreeger, W R Thayer
The American Journal of Digestive Diseases|February 1, 1973
The use of "medical by-pass" in the therapy of Crohn's disease: report of a caseG L Giorgini, R V Stephens, W R Thayer
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1971
Transabdominal vagectomy and lower esophageal functionA H Blackman, H Rakatansky, M Nasrullah, et al.
Journal of Clinical Gastroenterology|June 1, 1986
A negative search for four infectious agents in inflammatory bowel diseaseH J Van Kruiningen, E H Stephenson, W R Thayer
The American Journal of Digestive Diseases|September 1, 1971
Lactose intolerance in Jewish patients with ulcerative colitisR Tandon, H Mandell, H M Spiro, et al.
The American Journal of Clinical Nutrition|January 1, 1981
Clinical studies with low-lactose milkJ Reasoner, T P Maculan, A G Rand, et al.
Journal of Clinical Microbiology|April 1, 1990
Implications of antibodies to pyruvylated glucose in healthy populations for mycobacterioses and other infectious diseasesW R Thayer, C M Bozic, R T Camphausen, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Rhode Island Medical Journal|September 1, 1978
Toxic megacolon in inflammatory bowel disease: a new perspectiveR Carman, E A Iannuccilli, W R Thayer
Gastroenterology|February 1, 1976
The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) proteinP A Feinstein, S R Kaplan, W R Thayer
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1995
Rifabutin use in inflammatory bowel diseaseK W To, W G Tsiaras, W R Thayer
Antimicrobial Agents and Chemotherapy|August 1, 1993
Use of rifabutin in treatment of systemic Mycobacterium paratuberculosis infection in miceR J Chiodini, J M Kreeger, W R Thayer
The American Journal of Digestive Diseases|February 1, 1973
The use of "medical by-pass" in the therapy of Crohn's disease: report of a caseG L Giorgini, R V Stephens, W R Thayer
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1971
Transabdominal vagectomy and lower esophageal functionA H Blackman, H Rakatansky, M Nasrullah, et al.
Journal of Clinical Gastroenterology|June 1, 1986
A negative search for four infectious agents in inflammatory bowel diseaseH J Van Kruiningen, E H Stephenson, W R Thayer
The American Journal of Digestive Diseases|September 1, 1971
Lactose intolerance in Jewish patients with ulcerative colitisR Tandon, H Mandell, H M Spiro, et al.
The American Journal of Clinical Nutrition|January 1, 1981
Clinical studies with low-lactose milkJ Reasoner, T P Maculan, A G Rand, et al.
Journal of Clinical Microbiology|April 1, 1990
Implications of antibodies to pyruvylated glucose in healthy populations for mycobacterioses and other infectious diseasesW R Thayer, C M Bozic, R T Camphausen, et al.
Pageof 6